Correlation of activated STAT3 expression with clinicopathologic features in lung adenocarcinoma and squamous cell carcinoma.
about
Association of Nuclear PIM1 Expression with Lymph Node Metastasis and Poor Prognosis in Patients with Lung Adenocarcinoma and Squamous Cell CarcinomaDifferential roles of STAT3 in the initiation and growth of lung cancerBrassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxelPrognostic value of protein inhibitor of activated STAT3 in breast cancer patients receiving hormone therapy.Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma.Predictive and prognostic value of preoperative serum tumor markers is EGFR mutation-specific in resectable non-small-cell lung cancer.Claudin-1 correlates with poor prognosis in lung adenocarcinoma.A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: is EGFR mutation associated with a higher incidence of brain metastasis?Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapyThe Role of STAT3 in Non-Small Cell Lung Cancer.The involvement of JAK-STAT3 in cell motility, invasion, and metastasis.Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer.Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axis.Radiation promotes invasiveness of non-small-cell lung cancer cells through granulocyte-colony-stimulating factor.SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cells.Differential involvement of gp130 signalling pathways in modulating tobacco carcinogen-induced lung tumourigenesis.A new strategy in the treatment of chemoresistant lung adenocarcinoma via specific siRNA transfection of SRF, E2F1, Survivin, HIF and STAT3.Molecular mechanism underlying the antiproliferative effect of suppressor of cytokine signaling-1 in non-small-cell lung cancer cells.STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett's adenocarcinomas.STAT3, a Poor Survival Predicator, Is Associated with Lymph Node Metastasis from Breast Cancer.Fluorofenidone Inhibits the Proliferation of Lung Adenocarcinoma CellsHdac7 promotes lung tumorigenesis by inhibiting Stat3 activation.PD-L1 is a Prognostic Biomarker in Resected NSCLC Patients with Moderate/high Smoking History and Elevated Serum SCCA Level.A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation.EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma.Expression of EGFR and molecules downstream to PI3K/Akt, Raf-1-MEK-1-MAP (Erk1/2), and JAK (STAT3) pathways in invasive lung adenocarcinomas resected at a single institution.
P2860
Q27853352-79EBC16A-021D-4E77-A1C8-0961B6E83864Q35288058-2312084D-A235-410C-8CE2-82DA0046636CQ35742549-398FC40F-B600-4760-A397-E4C42635ABF4Q35894524-C0392B58-9D8D-4834-AF7C-9E783200D94BQ36805435-24022009-E5E0-449B-9ED9-56AEA3354343Q37295811-93622BAD-FFB6-41F4-8275-6154CCFF56FEQ37458453-FB0AECD9-444A-4478-B5DA-A4E9122BACA8Q37636737-BB5698CE-D5C1-438A-BD6C-20DD244B3935Q37702227-7B2BD9FC-7EF1-40DA-853F-65E795A58A36Q38199934-F7F8E5AF-8C13-477E-B917-94F38FD83872Q38208007-1EFC807A-23E1-489C-9180-E1DAD2122AABQ38369000-47C231EE-97EF-438B-B909-0B52FE3FB708Q38716717-9AE19BD9-AB06-44D4-A04F-55102E7D155BQ38914414-136A28DE-5D26-45ED-8498-F1B8944EADD6Q38994472-040893B7-ED2A-49C8-9A88-60A0872A8244Q39004659-389530AC-6278-43E8-87E3-B30D31029DCEQ39015690-BB0BC844-F0D1-4BFC-8A2D-CB7EA7A6A76AQ39107722-5B337705-183F-4CFA-8554-A731DAE5AF96Q39115912-8FD84AAF-FE9A-472F-8881-E3DDC97C155EQ39831857-62EFDBC1-7964-49AD-9FE6-FE7DC594B84CQ41396331-CF515E9A-50A0-4F1E-A306-4911018FE622Q46477219-90515AC5-C637-49F4-9713-A5036842A311Q47135594-480341A4-CBDF-4301-AC67-599EDC620F83Q47716658-48B4CFEA-3524-4CCD-B059-1581599D5F2DQ47780922-1522EC8D-E4FA-4964-AB78-377E0B9F3240Q54388141-E829E89B-6277-4A41-AC25-225ED17C22DE
P2860
Correlation of activated STAT3 expression with clinicopathologic features in lung adenocarcinoma and squamous cell carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Correlation of activated STAT3 ...... a and squamous cell carcinoma.
@en
Correlation of activated STAT3 ...... a and squamous cell carcinoma.
@nl
type
label
Correlation of activated STAT3 ...... a and squamous cell carcinoma.
@en
Correlation of activated STAT3 ...... a and squamous cell carcinoma.
@nl
prefLabel
Correlation of activated STAT3 ...... a and squamous cell carcinoma.
@en
Correlation of activated STAT3 ...... a and squamous cell carcinoma.
@nl
P2093
P2860
P356
P1476
Correlation of activated STAT3 ...... a and squamous cell carcinoma.
@en
P2093
Liuchun Wang
Richeng Jiang
Zhujun Liu
Ziliang Jin
P2860
P2888
P304
P356
10.1007/BF03256470
P577
2011-12-01T00:00:00Z